Citadel Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.62M | Buy |
1,143,806
+21,725
| +2% | +$30.9K | ﹤0.01% | 2869 |
|
2025
Q1 | $1.72M | Buy |
1,122,081
+1,066,734
| +1,927% | +$1.63M | ﹤0.01% | 2739 |
|
2024
Q4 | $137K | Sell |
55,347
-309,220
| -85% | -$767K | ﹤0.01% | 5048 |
|
2024
Q3 | $419K | Sell |
364,567
-510,649
| -58% | -$587K | ﹤0.01% | 3972 |
|
2024
Q2 | $963K | Sell |
875,216
-54,787
| -6% | -$60.3K | ﹤0.01% | 3079 |
|
2024
Q1 | $1.15M | Sell |
930,003
-4,458,786
| -83% | -$5.53M | ﹤0.01% | 3045 |
|
2023
Q4 | $5.66M | Buy |
5,388,789
+2,031,549
| +61% | +$2.13M | ﹤0.01% | 1571 |
|
2023
Q3 | $23M | Buy |
3,357,240
+744,166
| +28% | +$5.1M | ﹤0.01% | 730 |
|
2023
Q2 | $27.1M | Sell |
2,613,074
-494,690
| -16% | -$5.13M | 0.01% | 679 |
|
2023
Q1 | $25.1M | Buy |
3,107,764
+2,032,724
| +189% | +$16.4M | 0.01% | 748 |
|
2022
Q4 | $16.9M | Sell |
1,075,040
-43,377
| -4% | -$683K | ﹤0.01% | 961 |
|
2022
Q3 | $17.6M | Buy |
1,118,417
+165,345
| +17% | +$2.6M | ﹤0.01% | 911 |
|
2022
Q2 | $13.3M | Sell |
953,072
-19,128
| -2% | -$267K | ﹤0.01% | 1088 |
|
2022
Q1 | $16.8M | Sell |
972,200
-39,572
| -4% | -$682K | ﹤0.01% | 1038 |
|
2021
Q4 | $14.7M | Sell |
1,011,772
-51,845
| -5% | -$754K | ﹤0.01% | 1148 |
|
2021
Q3 | $19.1M | Sell |
1,063,617
-163,776
| -13% | -$2.95M | ﹤0.01% | 939 |
|
2021
Q2 | $21.6M | Sell |
1,227,393
-99,956
| -8% | -$1.76M | ﹤0.01% | 912 |
|
2021
Q1 | $33.4M | Buy |
1,327,349
+1,286,007
| +3,111% | +$32.4M | 0.01% | 664 |
|
2020
Q4 | $267K | Buy |
41,342
+16,238
| +65% | +$105K | ﹤0.01% | 4317 |
|
2020
Q3 | $65K | Buy |
+25,104
| New | +$65K | ﹤0.01% | 4344 |
|
2020
Q2 | – | Sell |
-51,250
| Closed | -$53K | – | 4582 |
|
2020
Q1 | $53K | Buy |
51,250
+24,479
| +91% | +$25.3K | ﹤0.01% | 4533 |
|
2019
Q4 | $51K | Sell |
26,771
-47,963
| -64% | -$91.4K | ﹤0.01% | 4389 |
|
2019
Q3 | $80K | Buy |
74,734
+42,281
| +130% | +$45.3K | ﹤0.01% | 4295 |
|
2019
Q2 | $71K | Sell |
32,453
-156,388
| -83% | -$342K | ﹤0.01% | 4304 |
|
2019
Q1 | $1.13M | Sell |
188,841
-365,497
| -66% | -$2.19M | ﹤0.01% | 2742 |
|
2018
Q4 | $4.1M | Sell |
554,338
-328,026
| -37% | -$2.42M | ﹤0.01% | 1627 |
|
2018
Q3 | $12.8M | Buy |
882,364
+14,134
| +2% | +$205K | 0.01% | 971 |
|
2018
Q2 | $17.3M | Sell |
868,230
-28,607
| -3% | -$571K | 0.01% | 773 |
|
2018
Q1 | $15.7M | Buy |
896,837
+748,422
| +504% | +$13.1M | 0.01% | 747 |
|
2017
Q4 | $3.66M | Sell |
148,415
-93,601
| -39% | -$2.31M | ﹤0.01% | 1504 |
|
2017
Q3 | $6.25M | Buy |
242,016
+208,429
| +621% | +$5.38M | ﹤0.01% | 1150 |
|
2017
Q2 | $911K | Sell |
33,587
-17,357
| -34% | -$471K | ﹤0.01% | 2217 |
|
2017
Q1 | $1.52M | Buy |
+50,944
| New | +$1.52M | ﹤0.01% | 1833 |
|
2016
Q4 | – | Sell |
-9,303
| Closed | -$238K | – | 3521 |
|
2016
Q3 | $238K | Buy |
+9,303
| New | +$238K | ﹤0.01% | 2954 |
|